A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression

ObjectiveThis study compares the safety and effectiveness of theta-burst stimulation (TBS) and repetitive transcranial magnetic stimulation (rTMS) for treating treatment-resistant depression (TRD).MethodsWe reviewed randomized controlled trials (RCTs) that evaluated rTMS and TBS in managing TRD. Sea...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Tao, Zheng Wen Jing, Wang Kui Yuan, Guo Hui Yun, Xie Jian Fang, Liao Ming Sheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1504727/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548276108263424
author Xiao Tao
Zheng Wen Jing
Wang Kui Yuan
Guo Hui Yun
Xie Jian Fang
Liao Ming Sheng
author_facet Xiao Tao
Zheng Wen Jing
Wang Kui Yuan
Guo Hui Yun
Xie Jian Fang
Liao Ming Sheng
author_sort Xiao Tao
collection DOAJ
description ObjectiveThis study compares the safety and effectiveness of theta-burst stimulation (TBS) and repetitive transcranial magnetic stimulation (rTMS) for treating treatment-resistant depression (TRD).MethodsWe reviewed randomized controlled trials (RCTs) that evaluated rTMS and TBS in managing TRD. Searches were conducted in PubMed, Embase, the Cochrane Library, and Web of Science for studies published up to July 31, 2024. Data from these studies were analyzed using statistical software.ResultsFive RCTs involving 1,196 patients were included, with 553 receiving rTMS and 663 receiving TBS. The analysis found no significant differences between rTMS and TBS in reducing depression [SMD = -0.07, 95% CI (-0.19, 0.04)] or anxiety [SMD = -0.02, 95% CI (-0.15, 0.11)], nor in side effects like headaches [OR = 1.00, 95% CI (0.72, 1.40)], nausea [OR = 1.42, 95% CI (0.79, 2.54)], or fatigue [OR = 0.87, 95% CI (0.46, 1.64)].ConclusionsBoth rTMS and TBS are similarly effective in reducing depression and anxiety symptoms, with comparable side effect profiles. However, TBS is more time-efficient, with sessions lasting only 192 seconds, making it a cost-effective option for patients. These findings support TBS as a practical treatment choice for TRD.
format Article
id doaj-art-8f48e0a33e3644f7a2af1ce3b1c6d03e
institution Kabale University
issn 1664-0640
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj-art-8f48e0a33e3644f7a2af1ce3b1c6d03e2025-02-03T06:33:27ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402025-02-011510.3389/fpsyt.2024.15047271504727A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depressionXiao TaoZheng Wen JingWang Kui YuanGuo Hui YunXie Jian FangLiao Ming ShengObjectiveThis study compares the safety and effectiveness of theta-burst stimulation (TBS) and repetitive transcranial magnetic stimulation (rTMS) for treating treatment-resistant depression (TRD).MethodsWe reviewed randomized controlled trials (RCTs) that evaluated rTMS and TBS in managing TRD. Searches were conducted in PubMed, Embase, the Cochrane Library, and Web of Science for studies published up to July 31, 2024. Data from these studies were analyzed using statistical software.ResultsFive RCTs involving 1,196 patients were included, with 553 receiving rTMS and 663 receiving TBS. The analysis found no significant differences between rTMS and TBS in reducing depression [SMD = -0.07, 95% CI (-0.19, 0.04)] or anxiety [SMD = -0.02, 95% CI (-0.15, 0.11)], nor in side effects like headaches [OR = 1.00, 95% CI (0.72, 1.40)], nausea [OR = 1.42, 95% CI (0.79, 2.54)], or fatigue [OR = 0.87, 95% CI (0.46, 1.64)].ConclusionsBoth rTMS and TBS are similarly effective in reducing depression and anxiety symptoms, with comparable side effect profiles. However, TBS is more time-efficient, with sessions lasting only 192 seconds, making it a cost-effective option for patients. These findings support TBS as a practical treatment choice for TRD.https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1504727/fulltranscranial magnetic stimulationtheta burst stimulationtreatment-resistant depressionmeta-analysisdepression
spellingShingle Xiao Tao
Zheng Wen Jing
Wang Kui Yuan
Guo Hui Yun
Xie Jian Fang
Liao Ming Sheng
A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
Frontiers in Psychiatry
transcranial magnetic stimulation
theta burst stimulation
treatment-resistant depression
meta-analysis
depression
title A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
title_full A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
title_fullStr A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
title_full_unstemmed A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
title_short A meta-analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment-resistant depression
title_sort meta analysis comparing the effectiveness and safety of repetitive transcranial magnetic stimulation versus theta burst stimulation for treatment resistant depression
topic transcranial magnetic stimulation
theta burst stimulation
treatment-resistant depression
meta-analysis
depression
url https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1504727/full
work_keys_str_mv AT xiaotao ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT zhengwenjing ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT wangkuiyuan ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT guohuiyun ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT xiejianfang ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT liaomingsheng ametaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT xiaotao metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT zhengwenjing metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT wangkuiyuan metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT guohuiyun metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT xiejianfang metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression
AT liaomingsheng metaanalysiscomparingtheeffectivenessandsafetyofrepetitivetranscranialmagneticstimulationversusthetaburststimulationfortreatmentresistantdepression